Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Motor Activity × Nivolumab × Clear all

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 47 Carcinoma, Non-Small-Cell Lung 31 Carcinoma, Renal Cell 24 Neoplasms 13 Neoplasm Metastasis 12 Carcinoma, Hepatocellular 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Lung Neoplasms 10 Adenocarcinoma Of Esophagus 10 Colorectal Neoplasms 9 Esophageal Neoplasms 7 Carcinoma, Transitional Cell 7 Skin Neoplasms 6 Sarcoma 6 Hodgkin Disease 6 Triple Negative Breast Neoplasms 5 Kidney Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Clear-cell metastatic renal cell carcinoma 5 Carcinoma, Merkel Cell 5 Breast Neoplasms 5 Brain Neoplasms 5 Uterine Cervical Neoplasms 4 Recurrence 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Glioblastoma 4 Colonic Neoplasms 4

Interventions

Exercise 28 Nutritional Status 4 Standard of Care 3 Control Groups 3 lime 2 Resistance Training 2 Preoperative Exercise 2 High-Intensity Interval Training 2 Fitness Trackers 2 Diet Therapy 2 tislelizumab 1 pembrolizumab 1 oncomodulin 1 diacetamate 1 beta-Glucans 1 Whey Proteins 1 Wearable Electronic Devices 1 Vitamin D 1 Telemedicine 1 Tea 1 Tablets 1 TEMPO 1 Spermine Synthase 1 Roflumilast 1 Rehabilitation 1 Probiotics 1 Physical Therapy Modalities 1 Physical Examination 1 Nutritional Support 1 Nutrition Assessment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡